Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-1463
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1) ; volume:127 ; number:1 ; day:18 ; month:12 ; year:2019 ; pages:51-59 ; date:1.2020
Journal of neural transmission ; 127, Heft 1 (18.12.2019), 51-59, 1.2020
- Urheber
-
Wilson, Heather
Pagano, Gennaro
Yousaf, Tayyabah
Polychronis, Sotirios
Micco, Rosa De
Giordano, Beniamino
Niccolini, Flavia
Politis, Marios
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00702-019-02125-6
- URN
-
urn:nbn:de:101:1-2020041219195539115660
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wilson, Heather
- Pagano, Gennaro
- Yousaf, Tayyabah
- Polychronis, Sotirios
- Micco, Rosa De
- Giordano, Beniamino
- Niccolini, Flavia
- Politis, Marios
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Neural correlates and predictors of subjective cognitive decline in patients with Parkinson’s disease
Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease
Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s Disease
Freezing of gait is a risk factor for cognitive decline in Parkinson’s disease
Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease
Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease
Proxy-analysis of the genetics of cognitive decline in Parkinson’s disease through polygenic scores
Polypharmacy Associated with Cognitive Decline in Newly Diagnosed Parkinson’s Disease: A Cross-Sectional Study
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline
Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Neural correlates and predictors of subjective cognitive decline in patients with Parkinson’s disease
Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease
Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s Disease
Freezing of gait is a risk factor for cognitive decline in Parkinson’s disease
Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease
Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease
Proxy-analysis of the genetics of cognitive decline in Parkinson’s disease through polygenic scores
Polypharmacy Associated with Cognitive Decline in Newly Diagnosed Parkinson’s Disease: A Cross-Sectional Study
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline
Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Neural correlates and predictors of subjective cognitive decline in patients with Parkinson’s disease
Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease
Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s Disease
Freezing of gait is a risk factor for cognitive decline in Parkinson’s disease
Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease
Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease
Proxy-analysis of the genetics of cognitive decline in Parkinson’s disease through polygenic scores
Polypharmacy Associated with Cognitive Decline in Newly Diagnosed Parkinson’s Disease: A Cross-Sectional Study